VYOME HOLDINGS, INC. Interest Expense Nonoperating
VYOME HOLDINGS, INC. (HIND) reported Interest Expense Nonoperating of $3.33 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-12
- VYOME HOLDINGS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $3.33K, a 94.08% decline year-over-year.
- VYOME HOLDINGS, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $2.85K, a 94.82% decline year-over-year.
- VYOME HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $9.94K, a 81.16% decline year-over-year.
- VYOME HOLDINGS, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $25.60K, a 44.03% decline year-over-year.
- VYOME HOLDINGS, INC. interest expense nonoperating for fiscal 2025 was $146.64K, a 28.82% decline from fiscal 2024.
- VYOME HOLDINGS, INC. interest expense nonoperating for fiscal 2024 was $206.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.33K 10-Q · filed 2026-08-12 | $6.17K 10-Q · filed 2026-08-12 | $16.11K derived: sum of 3 quarters · filed 2026-08-12 | $41.72K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $2.85K 10-Q · filed 2026-05-12 | $12.79K derived: sum of 2 quarters · filed 2026-05-12 | $38.39K derived: sum of 3 quarters · filed 2026-05-12 | $94.53K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $9.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $35.55K derived: sum of 2 quarters · filed 2026-03-18 | $91.69K derived: sum of 3 quarters · filed 2026-08-12 | $146.64K 10-K · filed 2026-03-18 |
| 2025-09-30 | $25.60K 10-Q · filed 2025-11-14 | $81.74K derived: sum of 2 quarters · filed 2026-08-12 | $136.70K 10-Q · filed 2025-11-14 | $189.47K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $56.14K 10-Q · filed 2026-08-12 | $111.09K 10-Q · filed 2026-08-12 | $163.87K derived: sum of 3 quarters · filed 2026-08-12 | $209.61K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $54.95K 10-Q · filed 2026-05-12 | $107.73K derived: sum of 2 quarters · filed 2026-05-12 | $153.47K derived: sum of 3 quarters · filed 2026-05-12 | |
| 2024-12-31 | $52.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $98.52K derived: sum of 2 quarters · filed 2026-03-18 | $206.00K 10-K · filed 2026-03-18 | |
| 2024-09-30 | $45.74K 10-Q · filed 2025-11-14 | $153.23K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | $107.49K 8-K · filed 2025-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |